Barely Significant
← all excerpts

Impact of Fusion Partners and Transplantation Benefit in Intensively Treated <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia.

Cancers (Basel) · 2026 · PMC12896996 · PMID 41681872

1
hedged sentence
closest p
boldest claim

The sentences

reported a more favorable prognosis for the KMT2A :: MLLT3 subgroup, with 5-year OS of 28%, although this difference did not reach statistical significance [ 26 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.